Description
Pharmacology: KEFIM is recommended by WHO in Typhoid and also recommended by Martindale in RTI. KEFIM exhibits high clinical success across indications, Drug of choice in Acute Otitis Media, achieves higher than 90% cure rates in Acute Exacerbation of Chronic Bronchitis also shortens therapy duration in Typhoid.
Dosage: One BID in Otitis Media, Typhoid, RTI, Acute Exacerbation of Chronic Bronchitis
